{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:28Z","timestamp":1762005328905,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In classical phenylketonuria (PKU) phenylalanine (Phe) accumulates due to functional impairment of the enzyme phenylalanine hydroxylase caused by pathogenic variants in the <jats:italic>PAH<\/jats:italic> gene. PKU treatment prevents severe cognitive impairment. Blood Phe concentration is the main biochemical monitoring parameter. Between appointments and venous blood sampling, Austrian PKU patients send dried blood spots (DBS) for Phe measurements to their centre. Coronavirus disease-19 (COVID-19), caused by the SARS CoV-2 virus, was classified as a pandemic by the World Health Organization in March 2020. In Austria, two nationwide lockdowns were installed during the first and second pandemic wave with variable regional and national restrictions in between. This retrospective questionnaire study compared the frequency of Phe measurements and Phe concentrations during lockdown with the respective period of the previous year in children and adolescents with PKU and explored potential influencing factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>77 patients (30 female, 47 male; mean age 12.4 [8\u201319] years in 2020) from five centres were included. The decline of venous samples taken on appointments in 2020 did not reach significance but the number of patients with none or only one DBS tripled from 4 (5.2%) in 2019 to 12 (15.6%) in 2020. Significantly more patients had a decline than a rise in the number of DBS sent in between 2019 and 2020 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; Chi<jats:sup>2<\/jats:sup>\u2009=\u200914.79). Especially patients\u2009\u2265\u200916\u00a0years sent significantly less DBS in 2020 (T\u2009=\u2009156, <jats:italic>p<\/jats:italic>\u2009=\u20090.02, r\u2009=\u20090.49). In patients who adhered to DBS measurements, Phe concentrations remained stable. Male or female sex and dietary only versus dietary plus sapropterin treatment did not influence frequency of measurements and median Phe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>During the COVID pandemic, the number of PKU patients who stopped sending DBS to their metabolic centre increased significantly, especially among those older than 16\u00a0years. Those who kept up sending DBS maintained stable Phe concentrations. Our follow-up system, which is based on DBS sent in by patients to trigger communication with the metabolic team served adherent patients well. It failed, however, to actively retrieve patients who stopped or reduced Phe measurements.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01996-x","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:18:41Z","timestamp":1629368321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria"],"prefix":"10.1186","volume":"16","author":[{"given":"Marion","family":"Herle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Brunner-Krainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Karall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Goeschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"M\u00f6slinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Plecko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Spenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia B.","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0590-678X","authenticated-orcid":false,"given":"Martina","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"issue":"1","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2008.05.013","volume":"83","author":"SW Gersting","year":"2008","unstructured":"Gersting SW, Kemter KF, Staudigl M, Messing DD, Danecka MK, Lagler FB, Sommerhoff CP, Roscher AA, Muntau AC. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet. 2008;83(1):5\u201317.","journal-title":"Am J Hum Genet"},{"key":"1996_CR2","unstructured":"http:\/\/www.biopku.org\/home\/pah.asp. Accessed 9 Dec 2020."},{"issue":"8","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41436-018-0403-z","volume":"21","author":"N Longo","year":"2019","unstructured":"Longo N, Dimmock D, Levy H, et al. Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genet Med. 2019;21(8):1851\u201367. https:\/\/doi.org\/10.1038\/s41436-018-0403-z.","journal-title":"Genet Med"},{"key":"1996_CR4","unstructured":"https:\/\/de.wikipedia.org\/wiki\/COVID-19-Pandemie_in_%C3%96sterreich. Accessed 14 April 2021."},{"issue":"12","key":"1996_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.paed.2020.09.004","volume":"30","author":"L Ashikkali","year":"2020","unstructured":"Ashikkali L, Carroll W, Johnson C. The indirect impact of COVID-19 on child health. Paediatr Child Health (Oxford). 2020;30(12):430\u20137. https:\/\/doi.org\/10.1016\/j.paed.2020.09.004.","journal-title":"Paediatr Child Health (Oxford)"},{"issue":"1","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12913-021-06284-9.PMID:33766026;PMCID:PMC7993902","volume":"21","author":"C Conlon","year":"2021","unstructured":"Conlon C, McDonnell T, Barrett M, Cummins F, Deasy C, Hensey C, McAuliffe E, Nicholson E. The impact of the COVID-19 pandemic on child health and the provision of Care in Paediatric Emergency Departments: a qualitative study of frontline emergency care staff. BMC Health Serv Res. 2021;21(1):279. https:\/\/doi.org\/10.1186\/s12913-021-06284-9.PMID:33766026;PMCID:PMC7993902.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1996_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ymgme.2020.09.004","volume":"131","author":"MA Elmonem","year":"2020","unstructured":"Elmonem MA, Belanger-Quintana A, Bordugo A, Boruah R, Cort\u00e8s-Saladelafont E, Endrakanti M, Giraldo P, Gr\u00fcnert SC, Gupta N, Kabra M, Knerr I, Kr\u00e4mer J, Kuster A, Levtchenko E, Ngu LH, Rovira-Remisa MM, Sass JO, Sykut-Cegielska J, Tummolo A, van den Heuvel LP. The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: a global perspective. Mol Genet Metab. 2020;131(3):285\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2020.09.004.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1996_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045813","volume":"11","author":"CC Topriceanu","year":"2021","unstructured":"Topriceanu CC, Wong A, Moon JC, Hughes AD, Bann D, Chaturvedi N, Patalay P, Conti G, Captur G. Evaluating access to health and care services during lockdown by the COVID-19 survey in five UK national longitudinal studies. BMJ Open. 2021;11(3): e045813. https:\/\/doi.org\/10.1136\/bmjopen-2020-045813.","journal-title":"BMJ Open"},{"key":"1996_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14380","author":"L D'Onofrio","year":"2021","unstructured":"D\u2019Onofrio L, Pieralice S, Maddaloni E, Mignogna C, Sterpetti S, Coraggio L, Luordi C, Guarisco G, Leto G, Leonetti F, Manfrini S, Buzzetti R. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. Diabetes Obes Metab. 2021. https:\/\/doi.org\/10.1111\/dom.14380.","journal-title":"Diabetes Obes Metab"},{"key":"1996_CR10","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. In: Second Edition. Lawrence Erlbaum Associates, Publishers; 1988"},{"key":"1996_CR11","unstructured":"https:\/\/www.graphpad.com\/quickcalcs\/. Accessed May 2021."},{"key":"1996_CR12","unstructured":"APS Empfehlungen. http:\/\/www.aps-med.de\/site\/store\/recommendations\/Therapy_of_patients_with_Phenylketonuria%20_DE.pdf. Accessed 22 April 2020."},{"key":"1996_CR13","first-page":"2","volume":"17","author":"D Ballhausen","year":"2006","unstructured":"Ballhausen D, Baumgartner M, Bonaf\u00e9 L, et al. Empfehlungen f\u00fcr die Behandlung der Phenylketonurie und Hyperphenylalanin\u00e4mie. Paediatrica. 2006;17:2.","journal-title":"Paediatrica"},{"key":"1996_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12:162.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1996_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","volume":"15","author":"A MacDonald","year":"2020","unstructured":"MacDonald A, van Wegberg AMJ, Ahring K, et al. PKU dietary handbook to accompany PKU guidelines [published correction appears in Orphanet J Rare Dis. 2020 Sep 1;15(1):230]. Orphanet J Rare Dis. 2020;15(1):171. https:\/\/doi.org\/10.1186\/s13023-020-01391-y.","journal-title":"Orphanet J Rare Dis"},{"key":"1996_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16:188\u2013200.","journal-title":"Genet Med"},{"key":"1996_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jpeds.2020.05.053","volume":"224","author":"I Somekh","year":"2020","unstructured":"Somekh I, Somech R, Pettoello-Mantovani M, Somekh E. Changes in routine pediatric practice in light of coronavirus 2019 (COVID-19). J Pediatr. 2020;224:190\u20133. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.053.","journal-title":"J Pediatr"},{"issue":"14","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/RMHP.S293471","volume":"15","author":"T Kendzerska","year":"2021","unstructured":"Kendzerska T, Zhu DT, Gershon AS, Edwards JD, Peixoto C, Robillard R, Kendall CE. The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review. Risk Manag Healthc Policy. 2021;15(14):575\u201384. https:\/\/doi.org\/10.2147\/RMHP.S293471.","journal-title":"Risk Manag Healthc Policy"},{"key":"1996_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.05.00","author":"M Beghini","year":"2021","unstructured":"Beghini M, Resch FJ, M\u00f6slinger D, Konstantopoulou V, Karall D, Scholl-B\u00fcrgi S, Brunner-Krainz M, Plecko B, Spenger J, Kautzky-Willer A, Scherer T, Hufgard-Leitner M. Project, \u201cBacktoclinic I\u201d: an overview on the state of care of adult PKU patients in Austria. Mol Genet Metab. 2021. https:\/\/doi.org\/10.1016\/j.ymgme.2021.05.00.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2017.01.001","volume":"120","author":"ER Jurecki","year":"2017","unstructured":"Jurecki ER, Cederbaum S, Kopesky J, Perry K, Rohr F, Sanchez-Valle A, Viau KS, Sheinin MY, Cohen-Pfeffer JL. Adherence to clinic recommendations among patients with phenylketonuria in the United States. Mol Genet Metab. 2017;120(3):190\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2017.01.001 (Epub 2017 Jan 6 PMID: 28162992).","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/nu13030799.PMID:33671057;PMCID:PMC8001271","volume":"13","author":"M Peres","year":"2021","unstructured":"Peres M, Almeida MF, Pinto \u00c9J, Carmona C, Rocha S, Guimas A, Ribeiro R, Martins E, Bandeira A, MacDonald A, Rocha JC. Implementing a transition program from paediatric to adult services in phenylketonuria: results after two years of follow-up with an adult team. Nutrients. 2021;13(3):799. https:\/\/doi.org\/10.3390\/nu13030799.PMID:33671057;PMCID:PMC8001271.","journal-title":"Nutrients"},{"key":"1996_CR22","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2020.0569","author":"T Zubarioglu","year":"2021","unstructured":"Zubarioglu T, Hopurcuoglu D, Uygur E, Ahmadzada S, Oge-Enver E, Isat E, Cansever MS, Kiykim E, Aktuglu-Zeybek C. The impact of telemedicine for monitoring and treatment of phenylketonuria patients on metabolic outcome during coronavirus disease-19 outbreak. Telemed J e-Health. 2021. https:\/\/doi.org\/10.1089\/tmj.2020.0569.","journal-title":"Telemed J e-Health."},{"issue":"4","key":"1996_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/24552","volume":"23","author":"M Parise","year":"2021","unstructured":"Parise M, Tartaglione L, Cutruzzol\u00e0 A, Maiorino MI, Esposito K, Pitocco D, Gnasso A, Irace C. Teleassistance for patients with type 1 diabetes during the COVID-19 pandemic: results of a pilot study. J Med Internet Res. 2021;23(4): e24552. https:\/\/doi.org\/10.2196\/24552 (PMID: 33769945).","journal-title":"J Med Internet Res"},{"key":"1996_CR24","doi-asserted-by":"publisher","first-page":"100759","DOI":"10.1016\/j.ymgmr.2021.100759","volume":"27","author":"V Rovelli","year":"2021","unstructured":"Rovelli V, Zuvadelli J, Ercoli V, Montanari C, Paci S, Dionigi AR, Scopari A, Salvatici E, Cefalo G, Banderali G. PKU and COVID19: how the pandemic changed metabolic control. Mol Genet Metab Rep. 2021;27:100759. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100759.","journal-title":"Mol Genet Metab Rep"},{"key":"1996_CR25","doi-asserted-by":"publisher","first-page":"108285","DOI":"10.1016\/j.diabres.2020.108285","volume":"166","author":"K Kanc","year":"2020","unstructured":"Kanc K, Komel J, Kos M, Wagner J. H(ome)bA1c testing and telemedicine: high satisfaction of people with diabetes for diabetes management during COVID-19 lockdown. Diabetes Res Clin Pract. 2020;166:108285. https:\/\/doi.org\/10.1016\/j.diabres.2020.108285.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1996_CR26","doi-asserted-by":"publisher","first-page":"1901407","DOI":"10.1080\/20008198.2021.1901407","volume":"12","author":"SJ Schmidt","year":"2021","unstructured":"Schmidt SJ, Barblan LP, Lory I, Landolt MA. Age-related effects of the COVID-19 pandemic on mental health of children and adolescents. Eur J Psychotraumatol. 2021;12(1):1901407. https:\/\/doi.org\/10.1080\/20008198.2021.1901407.","journal-title":"Eur J Psychotraumatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01996-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:21:05Z","timestamp":1629368465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01996-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01996-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2021,8,19]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used retrospective anonymised data only. Ethics approval and consent to participate were not necessary to be obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare no competing interests but disclose the following: MHu has received research grants from Nutricia Metabolics and consultancy honoraria from SOBI, Aeglea, Shire, Sanofi, and Orphan Europe. SSB has received research grants from Nutricia Metabolics and consultancy honoraria from Nutricia Metabolics and Dr. Sch\u00e4r. MHe, MBK, DK, BG, DM, BP, JS, JZ and SBW have nothing to disclose related to the contents of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}